menu close
tesseratherapeutics.com

Tessera Therapeutics Stock

Company Profile:

Tessera Therapeutics is an innovative life sciences company focused on pioneering a new biotechnology called Gene Writing™, which aims to revolutionize genetic medicine. Tessera is developing technologies that allow for precise and efficient modifications to the genome, addressing genetic diseases that traditional gene therapy and editing methods cannot effectively treat.

Sign up for SecondMarket™ to view the market and buy or sell Tessera Therapeutics Stock
Buy + Sell

Tessera Therapeutics Funding

Sign up to gain insights into Tessera Therapeutics funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Mar 08, 2022 Series C 400.00M
Price
Valuation
Jan 13, 2021 Series B 231.50M
Price
Valuation
Jan 13, 2021 Series A 5.00M
Price
Valuation
Sep 29, 2020 Series A 6.60M
Price
Valuation
Sep 30, 2019 Series A 13.81M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Tessera Therapeutics Management Team

  • Chief Data Officer

    Ian McFayden

  • Chief Medical and Development Officer

    David Davidson

  • Director

    Mary Rozenman

  • Chief Operating Officer

    Hari Pujar

  • Co-founder, Chief Innovation Officer

    Jake Rubens

  • Director

    Elliott Sigal

  • Chief Human Resources Officer

    Becky Lillie

  • Chief Scientific Officer

    Michael Holmes

  • CTO, Cell Therapy

    Madhusudan Peshwa

  • CFO, President

    Howard Liang

  • CEO, Director

    Michael Severino

  • Director

    Melissa Moore

  • Co-founder, Board Chair

    Geoffrey von Maltzahn

  • Director

    Noubar Afeyan

Tessera Therapeutics Major Investors

  • Qatar Investment Authority (QIA)

  • March Capital

  • Cormorant Asset Management

  • Hanwha Venture Capital Corporation

  • Alaska Permanent Fund (APFC)

  • Abu Dhabi Investment Authority (ADIA)

  • Artis Ventures

  • Longevity Fund, The

  • Longevity Fund, The

  • Softbank Vision Fund 2

  • Altitude Life Science Ventures

  • Flagship Pioneering

Learn More About Tessera Therapeutics Stock

Buy Tessera Therapeutics Stock
01
Tessera Therapeutics stock does not trade on public stock exchanges. Tessera Therapeutics stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Tessera Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Tessera Therapeutics Stock
02
Tessera Therapeutics Stock does not trade on public stock exchanges. In order to sell Tessera Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Tessera Therapeutics Stock Price
03
Tessera Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Tessera Therapeutics share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Tessera Therapeutics Stock Ticker Symbol
04
There is no ticker symbol for Tessera Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Tessera Therapeutics Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Tessera Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Tessera Therapeutics Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Tessera Therapeutics stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Tessera Therapeutics Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Tessera Therapeutics IPO
08
Tessera Therapeutics is a private company and has not had an IPO. There is currently no Tessera Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Tessera Therapeutics IPO.
Sign up for SecondMarket™ to view the market and buy or sell Tessera Therapeutics Stock
Buy + Sell

Other Companies

Unite Us

Provides best-in-class collaboration and coordination software, streamlining the delivery of health & social services

Sila Nanotechnologies

Battery manufacturer producing lithium–silicon batteries using nanoengineered silicon particles.

Quizlet

Provides learning software, giving users across the globe from grade school to grad school access to free, powerful, and inspiring learning tools.

Domino Data Lab

Enterprise data science platform.

Rothy’s

Stylish shoes, handbags, and accessories made from sustainable materials.

Opentrons Labworks

A developer of a pipetting robot technology designed to automate experiments.

Source: Nasdaq Private Market Tape D™